Global Nasal Cannula Market Insights Forecasts to 2033

• The Global Nasal Cannula Market Size was Valued at USD 7.95 Billion in 2023
• The Market Size is Growing at a CAGR of 6.43% from 2023 to 2033
• The Worldwide Nasal Cannula Market Size is Expected to Reach USD 14.82 Billion by 2033
• Asia Pacific is Expected to Grow the fastest during the forecast period.

The Global Nasal Cannula Market Size is Anticipated to Exceed USD 14.82 Billion by 2033, Growing at a CAGR of 6.43% from 2023 to 2033.

Market Overview

A nasal cannula is a medical device that provides additional oxygen (supplemental oxygen and oxygen therapy) through the nose. The nasal cannula is a thin, flexible tube that is put around the head and into the nose. There are two spikes that go inside the nostrils and supply oxygen. The tube is attached to the oxygen cylinder. There are two types of nasal cannulas: high-flow nasal cannulas and low-flow nasal cannulas. A nasal cannula is useful for those who have trouble breathing and are unable to get sufficient oxygen. Nasal cannulas are used in various health conditions, including asthma, chronic obstructive pulmonary disease, heart failure, pneumonia, COVID-19, and pulmonary fibrosis. The increasing need and adoption of nasal cannulas are reached by the rising number of manufacturers and suppliers globally. The overall healthcare sector has observed a remarkable surge in surgical procedures that require oxygen support in recent years. There has been a rise in the number of surgeries where patients need oxygen supplements. This growth is attributed to various factors, including geriatric patients having a higher prevalence of respiratory problems, an increase in complex surgical interference, and the growing scope of nasal cannula in procedures.

Report Coverage

This research report categorizes the market for the global nasal cannula market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the global nasal cannula market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the global nasal cannula market.

Driving Factors

A rising natural growth programme, like new products introduced by key companies to increase their product portfolios, is anticipated to drive the growth of the nasal cannula market during the predicted time period. The rising prevalence of asthma and chronic obstructive pulmonary disorder are major factors boosting market growth. Additionally, the prevalence of asthma is higher in females (9.8%) as compared to males (6.1%). As per the Interactive Summary of Health Statistics for Adults by the Centres for Disease Control (CDC), 3.5% of asthma occurred in geriatric patients in 2020. Therefore, patients with respiratory disorders often require high-flow oxygen therapy via nasal cannulas, thus the growing need for nasal cannulas is driving the growth of the nasal cannula market during the forecast period.

Restraining Factors

The rising use of nasal cannulas can also cause adverse effects, like the transmission of pathogenic viruses or bacteria through the cannula, which can cause infection in patients. This is predicted to hinder the growth of the market during the predicted timeframe. Long-term use of oxygen supplements can cause several side effects, such as airway damage (pulmonary oxygen toxicity), lung damage, and eye damage. These factors restrain the growth of the nasal cannula market over the predicted timeframe. 

Market Segmentation

The Global Nasal Cannula Market share is classified into type, material, and end-user.

• The low flow segment is anticipated to hold the largest share of the global nasal cannula market during the forecast time period.

On the basis of type, the global nasal cannula segment is divided into low flow and high flow. Among these, the low-flow segment is anticipated to hold the largest share of the global nasal cannula market during the forecast time period. Low-flow nasal cannulas are generally used to deliver an accurate and controlled amount of oxygen to a patient with a respiratory disorder. Nasal cannulas are affordable to patients who have low income and suitable for patients who require oxygen supplements in small amounts. The inventiveness and comfort of low-flow nasal cannulas make them favourable for long-term oxygen therapy. The acquisition of low-flow nasal cannulas is rising in home care, long-term care settings, and ambulatory settings where the patient is in a steady state and requires a low amount of oxygen.

• The plastic segment is anticipated to hold the largest share of the global nasal cannula market during the forecast time.

On the basis of material, the global nasal cannula market is divided into silicon and plastic. Among these, the plastic segment is anticipated to hold the largest share of the global nasal cannula market during the forecast time period. Plastic nasal cannulas are cost-effective for manufacturers as compared to silicon and are available globally. They are generally used in various healthcare sectors due to their affordability, which is selectively significant in markets with forecast restrictions. Plastic nasal cannulas are low in weight and generally easy for short-term use, making them a practical alternative for a wide range of patients who need oxygen therapy. Long-term users of plastic nasal cannulas show enhanced patient comfort and flexibility.  

• The hospital segment is anticipated to hold the largest share of the global nasal cannula market during the forecast time period.

On the basis of end-user, the global nasal cannula market is divided into hospital, specialty clinics, long-term care center, ACS, and homecare. Among these, the hospital segment is projected to hold the largest share of the global nasal cannula market during the forecast time period. The increasing geriatric population and patients with long-term respiratory disorders are predicted to support the growth of the market. Rising awareness among healthcare professionals and patients regarding the advantages of early diagnosis and treatment of respiratory problems could contribute to the growth of the market. Training initiatives related to the proper use of nasal cannulas and related devices may play an important role in boosting the growth of the nasal cannula market.

 Regional Segment Analysis of the Global Nasal Cannula Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the global nasal cannula market over the predicted timeframe.

North America is anticipated to hold the largest share of the global nasal cannula market over the predicted timeframe. A high prevalence of respiratory disorders, well-developed healthcare facilities, and favourable compensation policies are the factors that boost the market growth of this region. This region is identified by the presence of top market players, advanced technology, and a strong focus on improving respiratory care, which contributes to its power in the nasal cannula market. The rise in the incidence of respiratory disorders like asthma and COPD boosts market growth in this region. Additionally, the growth of local and international manufacturing companies makes possible the availability of products at an affordable price for customers. These factors are propelling the growth of the nasal cannula market in the North American region over the predicted timeframe.

Asia Pacific is anticipated to grow at the fastest rate in the global nasal cannula market during the forecast time period. Rising healthcare funding and growing local manufacturers are boosting market growth. The increase in the geriatric population led to a rise in respiratory disorders like asthma and chronic obstructive pulmonary disease. Additionally, improving healthcare facilities, a growing approach to healthcare services, and increasing demand for home healthcare solutions further drive the growth of the nasal cannula market in the Asia-Pacific region during the forecast period. 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global nasal cannula market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• ResMed Inc.
• Teleflex Incorporated
• Fisher & Paykel Healthcare Limited
• Allied Healthcare Products, Inc.
• Vygon
• Salter Labs
• Besmed Health Business Corp.
• Great Group Medical Co. Ltd.
• Drive DeVilbiss Healthcare
• Progetti S.r.l.
• Flexicare Medical
• MAQUET Holding B.V. & Co. KG
• GALEMed Corporation
• Fairmont Medical
• Vapotherm Inc.
• Smiths Medical
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments

• In November 2023, Smiths Medical launched its new OptiflowTM 5 HFNC system, developed for both geriatric and pediatric patients.

• In April 2021, Vapotherm, a medical technology company focused on the development and commercialization of its exclusive Hi-VNI Technology products that are used to treat patients suffering from respiratory disorders, introduced a major growth in its capital equipment manufacturing potential. The Precision Flow Hi-VNI system is a novel high-flow nasal cannula (HFNC) system using high velocity to treat the respiratory disorder suffered by COVID-19 patients.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the global nasal cannula market based on the below-mentioned segments: 

Global Nasal Cannula Market, By Type

• Low Flow
• High Flow

Global Nasal Cannula Market, By Material

• Silicon
• Plastic

Global Nasal Cannula Market, By End-User

• Hospital
• Specialty Clinic
• Long Term Care Center
• ASC
• Homecare

Global Nasal Cannula Market, Regional

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • Uk
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa